sb 203580 has been researched along with dieckol in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (dieckol) | Trials (dieckol) | Recent Studies (post-2010) (dieckol) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 97 | 2 | 82 |
| Protein | Taxonomy | sb 203580 (IC50) | dieckol (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 2.7 | |
| Beta-secretase 1 | Homo sapiens (human) | 2.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, W; Han, HJ; Jeon, YJ; Kim, HS; Lee, MY; Park, SH; Song, KS | 1 |
1 other study(ies) available for sb 203580 and dieckol
| Article | Year |
|---|---|
Protective effect of dieckol against chemical hypoxia-induced cytotoxicity in primary cultured mouse hepatocytes.
Topics: Animals; Benzofurans; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Cyclooxygenase 2; Dose-Response Relationship, Drug; Hepatocytes; Imidazoles; Male; Mice; Mice, Inbred ICR; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Sulfonamides; Time Factors | 2015 |